News Lilly's Lartruvo approved in US for soft tissue sarcoma Eli Lilly’s 'breakthrough' drug for soft tissue sarcoma, Lartruvo, has been approved by the FDA.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
